• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阵发性睡眠性血红蛋白尿症红细胞膜脂质的功能研究:脂质体对反应性溶解的敏感性

Functional study of lipids of PNH red cell membranes: susceptibility of liposomes to reactive lysis.

作者信息

Tedesco F, Kahane I, Zanella A, Giovanetti A M, Sirchia G

出版信息

Blood. 1981 May;57(5):900-5.

PMID:7214020
Abstract

Lipids extracted with chloroform-methanol from red blood cell membranes of 7 PNH and 13 control subjects were used for the preparation of liposomes, which were then examined with the reactive lysis test. PNH liposomes lysed to a higher extent than control liposomes as indicated by the higher dilution of the limiting complement reagent that was necessary to lyse 50% of the PNH liposomes. A similar finding was also observed with liposomes made of lipids from AET-treated red cells. The enhanced reactive lysis can be attributed to the polar lipid fraction, as indicated by the increased lysis of hybrid liposomes prepared from this polar lipids extracted from PNH erythrocyte membrane and lipids extracted from normal erythrocyte membrane. The increased susceptibility to reactive lysis does not seem to be specific of PNH liposomes, since it was also observed with liposomes prepared from lipids of red cells from beta-thalassemia major and autoimmune hemolytic disease.

摘要

用氯仿 - 甲醇从7名阵发性睡眠性血红蛋白尿(PNH)患者和13名对照受试者的红细胞膜中提取脂质,用于制备脂质体,然后用反应性溶解试验进行检测。PNH脂质体的溶解程度高于对照脂质体,这表现为溶解50%的PNH脂质体所需的极限补体试剂的稀释度更高。在用经AET处理的红细胞的脂质制成的脂质体中也观察到了类似的结果。反应性溶解增强可归因于极性脂质部分,这由从PNH红细胞膜提取的极性脂质和从正常红细胞膜提取的脂质制备的杂合脂质体的溶解增加所表明。对反应性溶解敏感性增加似乎并非PNH脂质体所特有,因为在由重型β地中海贫血和自身免疫性溶血性疾病患者的红细胞脂质制备的脂质体中也观察到了这一现象。

相似文献

1
Functional study of lipids of PNH red cell membranes: susceptibility of liposomes to reactive lysis.阵发性睡眠性血红蛋白尿症红细胞膜脂质的功能研究:脂质体对反应性溶解的敏感性
Blood. 1981 May;57(5):900-5.
2
Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.阵发性夜间血红蛋白尿症红细胞补体敏感性的特征分析
J Clin Invest. 1985 Jun;75(6):2074-84. doi: 10.1172/JCI111927.
3
An examination of complement proteins on membranes of paroxysmal nocturnal haemoglobinuria (PNH) and PNH-like red cells.阵发性睡眠性血红蛋白尿(PNH)及类PNH红细胞膜上补体蛋白的检测。
Br J Haematol. 1979 Mar;41(3):393-8. doi: 10.1111/j.1365-2141.1979.tb05872.x.
4
Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.体外红细胞免疫溶解机制。I. 阵发性夜间血红蛋白尿细胞。
J Clin Invest. 1973 May;52(5):1129-37. doi: 10.1172/JCI107279.
5
Differences in the terminal steps of complement lysis of normal and paroxysmal nocturnal hemoglobinuria red cells.
Blood. 1978 Feb;51(2):325-30.
6
Complement inhibitor S protein is associated with membranes of red blood cells from patients with paroxysmal nocturnal haemoglobinuria.
Br J Haematol. 1988 Jan;68(1):41-5. doi: 10.1111/j.1365-2141.1988.tb04177.x.
7
Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.反应性溶血膜抑制剂与阵发性夜间血红蛋白尿症红细胞表型之间的关系。
J Clin Invest. 1989 Nov;84(5):1387-94. doi: 10.1172/JCI114311.
8
Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.C5b-9对阵发性夜间血红蛋白尿红细胞的反应性溶解增强并不涉及C7结合增加或细胞结合的C3b增加。
J Immunol. 1985 Jan;134(1):506-11.
9
Altered red cell and platelet adhesion in hemolytic diseases: Hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell disease.溶血性疾病中红细胞和血小板黏附的改变:遗传性球形红细胞增多症、阵发性睡眠性血红蛋白尿和镰状细胞病。
Clin Biochem. 2013 Dec;46(18):1798-803. doi: 10.1016/j.clinbiochem.2013.09.011. Epub 2013 Sep 21.
10
Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.III型阵发性夜间血红蛋白尿。缺乏限制C5b-9介导红细胞溶解的红细胞膜蛋白。
J Clin Invest. 1987 Jul;80(1):7-12. doi: 10.1172/JCI113065.